Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its target price decreased by equities research analysts at Leerink Partners from $980.00 to $862.00 in a research note issued on Tuesday.

Diabetic retinopathy is a severe complication of diabetes that can lead to blindness. The Japanese clinical practice ...

Alvotech (ALVO) and Teva Pharmaceuticals (TEVA) announced that the FDA has accepted for review a Biologics License Application, or BLA, for ...

The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with diabetic macular edema (DME) who have previously responded to at least 2 ...

In addition to AVT06, which is a biosimilar candidate for Eylea ® (aflibercept) 2 mg, Alvotech is currently also developing AVT29, a biosimilar candidate for Eylea ® HD (aflibercept) 8 mg. Teva also ...

Abnormally high levels of fats in the bloodstream have previously been linked to eye conditions like macular degeneration and diabetic retinopathy, researchers said in background notes.

Abnormally high levels of fats in the bloodstream have previously been linked to eye conditions like macular degeneration and diabetic retinopathy, researchers said in background notes. But findings ...

Changes in your vision should prompt an urgent doctor’s visit as high blood sugar levels damage the retina’s blood vessels which can lead to permanent complications like diabetic retinopathy.

The family of a dad who died days after undergoing weight loss surgery worth £12,500 at a Surrey hospital are suing the firm ...